Feasibility of Virtual Reality-assisted Ergometer Cycling in Addition to Regular Rehabilitation During Municipality-based Inpatient Rehabilitation Care
VR-C-REHAB
1 other identifier
interventional
20
1 country
2
Brief Summary
VR-C-REHAB is a single-group pilot and feasibility study examining the practicality of implementing virtual-reality-assisted ergometer cycling as an adjunct to usual municipal inpatient rehabilitation for older adults (≥65 years). Many individuals admitted to temporary inpatient care present with low physical activity levels and fluctuating motivation, reducing the achievable exercise dose. Virtual reality may enhance engagement, enjoyment, and adherence, but its feasibility in this setting must be evaluated before conducting a future effect trial. The primary objective is to determine whether participants can achieve an adequate exercise dose, defined as the proportion of completed VR-cycling sessions out of those offered (target: ≥75%). Secondary feasibility outcomes include recruitment rate, safety and acceptability, and total cycling time. Exploratory outcomes include change in the 10-Meter Walk Test and session-level motivation (0-10). The intervention consists of 20 minutes of VR-assisted cycling, three times weekly for up to four weeks, delivered alongside standard rehabilitation. Data are collected at baseline, during each session, and at completion. Analyses are descriptive, focusing on the precision of feasibility estimates. Progression criteria (Go/Amend/Stop) are based on adherence, recruitment, and safety. The results will inform the design and implementation of a subsequent controlled study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedStudy Start
First participant enrolled
March 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2026
March 9, 2026
March 1, 2026
3 months
March 1, 2026
March 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Exercise Adherence: In percent
Definition: NumbercompletedVR-bicyclessessions/ NumberofferedVR-bicyclesessioner pr. participant, summarised and/or averaged for the entire cohort. The feasibility goal is set at ≥75%. "Offered sessions" are defined as the planned three weekly sessions during the period the participant is admitted and available, excluding days with clearly documented contraindications or acute illness according to predetermined criteria. The reasons for lack of training will be explicitly described in the manual as "illness," covering biological illness or other admitted causes, and "demotivation," which encompasses reasons such as tiredness, demotivation, or discomfort. The actual cause will be described.
4 weeks (at every exercise session)
Secondary Outcomes (4)
1. Recruitment Rate: Percent
Baseline testing (day 0)
walk speed
baseline testing and follow up testing after ending the intervention( up to 4 weeks later)
Motivation
during every session from enrollment until end of intervention (max 4 weeks)
Total Time Spent Cycling in minutes
Week 4 (or after conclusion of the intervention if that happens before)
Other Outcomes (1)
Safety/Acceptability (Recommended in Feasibility):
4 weeks (at every exercise session if it occurs)
Study Arms (1)
Intervention
EXPERIMENTALInterventions
* Intervention: 20 minutes of cycling with VR goggles in addition to regular treatment. * Frequency: Three times weekly. * Duration: Up to 4 weeks (dependent on discharge timing). * Delivery: Supervised by physiotherapists or therapeutic staff according to local practices.
Eligibility Criteria
You may qualify if:
- Age ≥65 years
- Referred to rehabilitation during a stay at temporary inpatient care
- Assessed by a therapist as capable of participating in seated cycling (possibly supervised)
- Able to provide informed consent (with relevant support according to local guidelines, if necessary).
You may not qualify if:
- Medical contraindications to moderate physical activity/cycling (e.g., unstable angina, uncontrolled arrhythmia, acute infection with significant impact)
- Severe dizziness/vestibular symptoms likely to be exacerbated by VR use
- Known photosensitive epilepsy or other conditions posing significant risk with VR stimulation
- Unresolved vision/perception issues or severe nausea rendering VR use unsuitable
- Participation in another intervention study that interferes with this intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Bispebjerg Hospital
Copenhagen, Denmark
Sundheds- og rehabiliteringscenter Hørsholm
Hørsholm, 2970, Denmark
Related Publications (4)
Mocco A, Valmaggia L, Bernardi L, Alfieri M, Tarricone I. Enhancing Physical Activity with Immersive Virtual Reality: A Systematic Review. Cyberpsychol Behav Soc Netw. 2024 May;27(5):303-317. doi: 10.1089/cyber.2023.0394. Epub 2024 Mar 20.
PMID: 38506442BACKGROUNDHajder Đ,Bjelica B,Bubanj S,Aksović N,Marković M,Arsenijević R,Lupu GS,Gašić T,Sufaru C,Toskić L,Dobreci DL,Dobrescu T,Sava MA
BACKGROUNDRytterström P,Strömberg A,Jaarsma T,Klompstra L
BACKGROUNDCampo-Prieto P,Cancela-Carral JM,Rodríguez-Fuentes G
BACKGROUND
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research and developement therapist, Msc. PT, PhD Candidate
Study Record Dates
First Submitted
March 1, 2026
First Posted
March 9, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
July 1, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be alailable from june 2026 onwards
- Access Criteria
- By contacting PI data will be provided on request.
Anonymized data on all outcomes will be provided upon request during or after a publication proces.